Valerio, Massimo
Emberton, Mark
Eggener, Scott E.
Ahmed, Hashim U.
Article History
First Online: 15 December 2015
Competing interests
: M.E. and H.U.A. have received funding for clinical trials from Advanced Medical Diagnostics, GSK, Hitachi, Immodulon, Sonacare, Sophiris Biocorp and Trod Medical and have previously acted as consultants for Oncura/GE Healthcare and Steba Biotech. M.E. is a consultant of Sonacare and Steba Biotech, has share options in Nuada Medical and is a director on the board of this company. S.E.E. has received research support from Myriad and is a consultant of Myriad, NxThera and Profound Medical. M.V. declares no competing interests.